Sign In
Buy HSY
$182.71
-0.490 (-0.267%)
At Close: Jun 04, 2026
3 Stocks Feeling the Weight of the Ozempic Effect
06:20am, Thursday, 14'th Dec 2023
The new class of weight loss drugs such as Ozempic and Zepbound are having a profound impact not only on the pharmaceutical and healthcare industries but also on areas of the economy ranging from gyms
3 of the Most Attractive Dividend Stocks in the Consumer Staples Space
12:10pm, Wednesday, 13'th Dec 2023
Consumer staples have been a defensive sector, especially during market downturns. Historically, they have outperformed the market during bear markets.
Weight loss drugs' impact on food stocks so far
05:40pm, Monday, 11'th Dec 2023
Yahoo Finance selected pharmaceutical firm Novo Nordisk (NVO) as it's 2023 Company of the Year. Developer of obesity medications Wegovy and Ozempic, Novo Nordisk stock has gained over 40% year-to-date
94% of Hershey's Profit Comes From Candy. But the Future Success of Its Business Is Riding on Something Else Entirely.
09:00am, Sunday, 10'th Dec 2023
Hershey's strategy changed -- for the better -- when its current CEO took over in 2017. Moving beyond candy has provided the company with some of its best growth in years.
Hershey: Sector Rotation Could Lead To Significant Upside In 2024
01:00am, Saturday, 09'th Dec 2023
The Hershey Company is a strong candidate for investment as it is growing its top and bottom line, buying back shares, and providing dividend growth to shareholders. Hershey's brand awareness is high,
Hershey (HSY) Stock Falls Amid Market Uptick: What Investors Need to Know
07:32pm, Friday, 08'th Dec 2023
Hershey (HSY) closed the most recent trading day at $185.74, moving -1.76% from the previous trading session.
What Charlie Munger and Grandma Ruth taught this money manager. His portfolio is up 50% this year.
01:46am, Wednesday, 06'th Dec 2023
At the start of 2023 and following a tough year, Christopher Tsai, president and chief investment officer of Tsai Capital, didn't think technology would generate a 50% return for his $110 million port
The Hershey Company: Deep-Dive Analysis Reveals A Tasty Opportunity
03:16pm, Wednesday, 29'th Nov 2023
The Hershey Company is the largest confectionary manufacturer in the U.S. with over 100 brand names sold across 80 different countries. The company has successfully built strong brands with lasting pr
Hershey (HSY) Looks Promising on Pricing Actions & Innovations
01:32pm, Friday, 24'th Nov 2023
Hershey (HSY) continues to invest in its brands and capabilities to drive growth. Management is undertaking strategic pricing initiatives to improve its performance.
Stability Seekers: 7 Low-Volatility Stocks for Uncertain Times
04:02pm, Thursday, 23'rd Nov 2023
At first blush, focusing on low-volatility stocks may appear an overly pessimistic strategy. After all, the benchmark S&P 500 gained almost 8% in the trailing month.
1 Subtle and Strange Reason Why I'm Happy I Bought Hershey Stock
07:40am, Thursday, 23'rd Nov 2023
Hershey is one of the largest confection makers in the United States. The company has growth opportunities in foreign markets and via salty snacks.
The Best Dividend Stocks to Buy Right Now Could be Hiding in Plain Sight
07:15am, Thursday, 23'rd Nov 2023
Consumer staples companies have a long history of being reliable dividend payers. Some have been hit hard by Wall Street concerns and weakening performance.
All Dividend Companies Have One Big Problem In Common
01:00pm, Tuesday, 14'th Nov 2023
Dividend investing is struggling in the current macroeconomic environment due to high interest rates. The yield on T-Bonds disincentivizes investors from buying dividend companies, leading to a drop i
3 Blue-Chip Stocks to Buy for Safety Amid the Volatility
09:42am, Tuesday, 14'th Nov 2023
As we head towards the year's end, several market uncertainties exist. Stalling disinflation, rising bond yields, war escalation and dysfunction in Washington are all looming challenges.
Who's afraid of Ozempic? From restaurants to package makers, companies work to calm investors' GLP-1 jitters.
11:13am, Friday, 10'th Nov 2023
That's the message from many corporate executives who have lately been peppered with questions about how Wegovy, Ozempic and other drugs widely used for weight loss may impact their bottom line.
